Printer Friendly

Articles from The Fly (December 2, 2018)

1-13 out of 13 article(s)
Title Author Type Words
AbbVie presents new data from Phase 3 MURANO trial of VENCLEXTA/VENCLYXTO. 397
BeiGene announces results of Zanubrutinib in Mantle Cell Lymphoma. Financial report 733
Bellicum announces favorable interim event-free survival data for rivo-cel. 150
Bellicum announces interim results showing rimiducid controlled GvHD. Financial report 334
Bluebird Bio presents updated data from clinical studies of LentiGlobin. Clinical report 762
Catalyst announces positive data from Phase 2/3 study of Marzeptacog Alfa. 302
Celgene, Acceleron announce results of Phase 3 BELIEVE trial. 178
Karyopharm reports positive top-line Phase 2b SADAL data for Selinexor. 189
Magenta presents new data on MGTA-145 stem cell mobilization product candidate. 185
MEI data shows Voruciclib synergistically induces apoptosis in Venetoclax combo. 117
Regeneron presents positive data at for REGN1979 CD20xCD3 bispecific antibody. 385
Seattle Genetics highlights data sets evaluating ADCETRIS, Opdivo combo at ASH. 471
Trump, Xi agree to halt imposition of new tariffs for 90 days, Bloomberg reports. 141

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters